Beas F, Vargas L, Spada RP, Merchak N. Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens. J Pediatr 1969;75:127–30.
Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L. An epidemic of precocious development in Puerto Rican children. J Pediatr 1985;107:393–6.
Tiwary CM. Premature sexual development in children following the use of estrogen- or placenta-containing hair products. Clin Pediatr (Phila) 1998;37:733–9.
Weber WW, Grossman M, Thom JV, Sax J, Chan JJ, et al. Drug contamination with diethylstilbestrol. Outbreak of precocious puberty due to contaminated isonicocinic acid hydrazide (INH). N Engl J Med 1963;268:411–5.
Zimmerman PA, Francis GL, Poth M. Hormone-containing cosmetics may cause signs of early sexual development. Mil Med 1995;160:628–30.
Yu YM, Punyasavatsu N, Elder D, D’Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics 1999;104:e23. [Web of Science]
Kunz GJ, Klein KO, Clemons RD, Gottschalk ME, Jones KL. Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114:282–4.
Franklin SL, Geffner ME. Precocious puberty secondary to topical testosterone exposure. J Pediatr Endocrinol Metab 2003;16:107–10. [PubMed]
Svoren BM, Wolfsdorf JI. Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metab 2005;18: 507–10.
Stephen MD, Jehaimi CT, Brosnan PG, Yafi M. Sexual precocity in a 2-year-old boy caused by indirect exposure to testosterone cream. Endocr Pract 2008;14:1027–30. [Crossref]
Brachet C, Vermeulen J, Heinrichs C. Children’s virilization and the use of a testosterone gel by their fathers. Eur J Pediatr 2005;164:646–7.
Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila) 2007;46:540–3. [Web of Science]
Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001;86:5108–17.
Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients – 2002 update. Endocr Pract 2002;8:440–56. [PubMed]
Conway AJ, Handelsman DJ, Lording DW, Stuckey B, Zajac JD. Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing. Med J Aust 2000;172:220–4.
Cuzin B, Giuliano F, Jamin C, Legros JJ, Lejeune H, et al. [Investigation, treatment and surveillance of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Aging Male (ISSAM) with comments]. Prog Urol 2004;14:1–14.
Franklin SL. Effects of unintentional exposure of children to compounded transdermal sex hormone therapy. Pediatr Endocrinol Rev 2011;8:208–12. [PubMed]
Kirschner MA. Hirsutism and virilism in women. Spec Top Endocrinol Metab 1984;6:55–93. [PubMed]
Kathiresan AS, Carr BR, Attia GR. Virilization from partner’s use of topical androgen in a reproductive-aged woman. Am J Obstet Gynecol 2011;205:e3–4. [Web of Science]
Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007;87:976.e13–5. [Web of Science]
Klugo RC, Cerny JC. Response of micropenis to topical testosterone and gonadotropin. J Urol 1978;119:667–8.
Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, et al. Transdermal testosterone therapy in the treatment of male hypogonadism. J Clin Endocrinol Metab 1988;66:546–51.
Wilson JD, Walker JD. The conversion of testosterone to 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest 1969;48:371–9.
Herman-Giddens ME, Sandler AD, Friedman NE. Sexual precocity in girls. An association with sexual abuse? Am J Dis Child 1988;142:431–3.
Guthrie RD, Smith DW, Graham CB. Testosterone treatment for micropenis during early childhood. J Pediatr 1973;83:247–52.
Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 1997;46:513–7.
Husmann DA, Cain MP. Microphallus: eventual phallic size is dependent on the timing of androgen administration. J Urol 1994;152:734–9.
McMahon DR, Kramer SA, Husmann DA. Micropenis: does early treatment with testosterone do more harm than good? J Urol 1995;154:825–9.
Sutherland RS, Kogan BA, Baskin LS, Mevorach RA, Conte F, et al. The effect of prepubertal androgen exposure on adult penile length. J Urol 1996;156:783–7; discussion 787.